Danaher Co. (NYSE:DHR) Shares Purchased by RWA Wealth Partners LLC

RWA Wealth Partners LLC boosted its position in shares of Danaher Co. (NYSE:DHR) by 8.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 12,856 shares of the conglomerate’s stock after acquiring an additional 960 shares during the period. RWA Wealth Partners LLC’s holdings in Danaher were worth $2,951,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Danaher during the 4th quarter valued at about $2,130,740,000. Raymond James Financial Inc. purchased a new position in Danaher during the fourth quarter worth approximately $391,172,000. Van ECK Associates Corp grew its holdings in Danaher by 6,862.7% in the fourth quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock valued at $213,452,000 after purchasing an additional 916,513 shares during the period. Parnassus Investments LLC increased its position in shares of Danaher by 31.8% in the fourth quarter. Parnassus Investments LLC now owns 3,105,388 shares of the conglomerate’s stock valued at $712,842,000 after buying an additional 749,136 shares in the last quarter. Finally, Proficio Capital Partners LLC raised its stake in shares of Danaher by 29,287.7% during the 4th quarter. Proficio Capital Partners LLC now owns 588,929 shares of the conglomerate’s stock worth $135,189,000 after buying an additional 586,925 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Stock Down 2.1 %

Shares of NYSE DHR opened at $205.69 on Monday. The company has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a 50 day simple moving average of $214.57 and a 200-day simple moving average of $236.39. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business earned $2.09 earnings per share. On average, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.62%. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Guggenheim started coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Scotiabank assumed coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, Raymond James reissued a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $278.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.